Related Experiment Video
Updated: Jun 13, 2026
Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
Published on: August 28, 2012
[Expression and purification of a recombinant transmembrane domain amyloid precursor protein associated with
Abstract:
More than half of the mutations of the amyloid precursor protein (APP) discovered in familiar forms of Alzheimer's disease are located in the transmembrane domain. The pathogenic mutations presumably affect the lateral dimerization of the APP transmembrane domain in the membrane and change the dimer conformation and/or stability. Thus, the mutations cause an alternative APP digestion pattern in the membrane and neurotoxic amyloid beta-peptide generation. For the detailed study of the specific protein-protein and protein-lipid interactions of the APP transmembrane domain, an E. coli recombinant expression construct was made. The recombinant protein contains an APP transmembrane domain (APPtm(686-726)) with adjacent extramembrane N and C ends. Here, we report the method of isotope-labeled APPtm expression and purification in quantities necessary for a heteronuclear NMR spectroscopy structure and dynamics study. On the basis of the (1)H-(15)N-HSQC spectra, we developed APPtm(686-726) solubilization conditions in the membrane-emulated milieu detergent micelles and lipid bicelles.
Insights
Familial Alzheimer's disease mutations in amyloid precursor protein (APP) transmembrane domain affect dimerization, altering APP processing and generating neurotoxic peptides. This study details isotope-labeled APPtm expression and purification for structural and dynamic studies using NMR spectroscopy.
Area of Science:
- Biochemistry
- Neuroscience
- Structural Biology
Background:
- Familial Alzheimer's disease is linked to mutations in the amyloid precursor protein (APP), with over half located in its transmembrane domain.
- These mutations are hypothesized to disrupt APP transmembrane domain dimerization, affecting protein processing and amyloid-beta peptide generation.
Purpose of the Study:
- To investigate the protein-protein and protein-lipid interactions of the APP transmembrane domain.
- To develop a method for expressing and purifying isotope-labeled APP transmembrane domain (APPtm) for structural and dynamic studies.
Main Methods:
- Engineered an E. coli recombinant expression construct for APPtm(686-726) with adjacent extramembrane regions.
- Utilized isotope labeling for protein expression and purification.
- Employed heteronuclear NMR spectroscopy, specifically (1)H-(15)N-HSQC spectra, to assess protein behavior.
Main Results:
- Successfully expressed and purified sufficient quantities of isotope-labeled APPtm(686-726).
- Identified optimal solubilization conditions for APPtm(686-726) in membrane-mimicking environments, including detergent micelles and lipid bicelles.
- Established the feasibility of using NMR spectroscopy for structural and dynamic studies.
Conclusions:
- The developed method enables detailed structural and dynamic investigations of the APP transmembrane domain.
- Understanding APPtm interactions is crucial for elucidating Alzheimer's disease pathogenesis.
- This work lays the foundation for future studies on APP processing and therapeutic target identification.
